Literature DB >> 15143160

Mutations in the SAM domain of the ETV6-NTRK3 chimeric tyrosine kinase block polymerization and transformation activity.

Cristina E Tognon1, Cameron D Mackereth, Aruna M Somasiri, Lawrence P McIntosh, Poul H B Sorensen.   

Abstract

The 12p13 ETV6 (TEL) gene is frequently targeted by chromosomal translocations in human malignancies, resulting in the formation of oncogenic ETV6 gene fusions. Many of the known partner genes encode protein tyrosine kinases (PTKs), generating fusion proteins that function as chimeric PTKs. ETV6-NTRK3 (EN), comprised of the ETV6 SAM domain fused to the NTRK3 PTK, is unique among ETV6 chimeric oncoproteins, as it is expressed in cancers of multiple lineages. We initially hypothesized that, similar to other ETV6-PTK chimeras, SAM-mediated dimerization of EN leads to constitutive activation of the PTK and downstream signaling cascades. However, when the EN SAM domain was replaced with an inducible FK506 binding protein (FKBP) dimerization system, resulting FKBP-NTRK3 chimeras failed to transform NIH 3T3 cells even though PTK activation was preserved. It was recently shown that the ETV6 SAM domain has two potential interacting surfaces, raising the possibility that this domain can mediate protein polymerization. We therefore mutated each EN SAM binding interface in a manner shown previously to abolish self-association of wild-type ETV6. Each mutation completely blocked the ability of EN to polymerize, to activate its PTK, and to transform NIH 3T3 cells. Furthermore, EN itself formed large polymeric structures within cells while mutant EN proteins were present only as monomers. Finally, we observed a dominant negative effect on the transformation of isolated SAM domains coexpressed in EN-transformed cells. Taken together, our results suggest that higher-order polymerization may be a critical requirement for the transformation activity of EN and possibly other ETV6-PTK fusion proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15143160      PMCID: PMC416412          DOI: 10.1128/MCB.24.11.4636-4650.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  Characterization of the chronic myelomonocytic leukemia associated TEL-PDGF beta R fusion protein.

Authors:  T Sjöblom; A Boureux; L Rönnstrand; C H Heldin; J Ghysdael; A Ostman
Journal:  Oncogene       Date:  1999-11-25       Impact factor: 9.867

2.  Monomeric structure of the human EphB2 sterile alpha motif domain.

Authors:  C D Thanos; S Faham; K E Goodwill; D Cascio; M Phillips; J U Bowie
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

Review 3.  Oncogenic kinase signalling.

Authors:  P Blume-Jensen; T Hunter
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

4.  The tyrosine kinase abl-related gene ARG is fused to ETV6 in an AML-M4Eo patient with a t(1;12)(q25;p13): molecular cloning of both reciprocal transcripts.

Authors:  G Cazzaniga; S Tosi; A Aloisi; G Giudici; M Daniotti; P Pioltelli; L Kearney; A Biondi
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

5.  A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation.

Authors:  Y Iijima; T Ito; T Oikawa; M Eguchi; M Eguchi-Ishimae; N Kamada; K Kishi; S Asano; Y Sakaki; Y Sato
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

6.  The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.

Authors:  D H Wai; S R Knezevich; T Lucas; B Jansen; R J Kay; P H Sorensen
Journal:  Oncogene       Date:  2000-02-17       Impact factor: 9.867

7.  The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion.

Authors:  F Salomon-Nguyen; V Della-Valle; M Mauchauffe; M Busson-Le Coniat; J Ghysdael; R Berger; O A Bernard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

8.  Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers.

Authors:  R J Lin; R M Evans
Journal:  Mol Cell       Date:  2000-05       Impact factor: 17.970

Review 9.  Fusion genes in leukemia: an emerging network.

Authors:  S K Bohlander
Journal:  Cytogenet Cell Genet       Date:  2000

10.  The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow.

Authors:  L C Wang; W Swat; Y Fujiwara; L Davidson; J Visvader; F Kuo; F W Alt; D G Gilliland; T R Golub; S H Orkin
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

View more
  17 in total

1.  The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.

Authors:  Matthew J Martin; Nataliya Melnyk; Michelle Pollard; Mary Bowden; Hon Leong; Thomas J Podor; Martin Gleave; Poul H B Sorensen
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

2.  DNA Occupancy of Polymerizing Transcription Factors: A Chemical Model of the ETS Family Factor Yan.

Authors:  C Matthew Hope; Ilaria Rebay; John Reinitz
Journal:  Biophys J       Date:  2017-01-10       Impact factor: 4.033

3.  The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-beta signaling by inactivating the TGF-beta type II receptor.

Authors:  Wook Jin; Byung-Chul Kim; Cristina Tognon; Ho-Jae Lee; Sejal Patel; Chris L Lannon; John M Maris; Timothy J Triche; Poul H B Sorensen; Seong-Jin Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-28       Impact factor: 11.205

4.  NTRK3 kinase fusions in Spitz tumours.

Authors:  Iwei Yeh; Meng Kian Tee; Thomas Botton; A Hunter Shain; Alyssa J Sparatta; Alexander Gagnon; Swapna S Vemula; Maria C Garrido; Kenji Nakamaru; Takeshi Isoyama; Timothy H McCalmont; Philip E LeBoit; Boris C Bastian
Journal:  J Pathol       Date:  2016-11       Impact factor: 7.996

5.  Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformation.

Authors:  Naniye Cetinbas; Helen Huang-Hobbs; Cristina Tognon; Gabriel Leprivier; Jianghong An; Steven McKinney; Mary Bowden; Connie Chow; Martin Gleave; Lawrence P McIntosh; Poul H Sorensen
Journal:  J Biol Chem       Date:  2013-06-24       Impact factor: 5.157

Review 6.  ABL tyrosine kinases: evolution of function, regulation, and specificity.

Authors:  John Colicelli
Journal:  Sci Signal       Date:  2010-09-14       Impact factor: 8.192

7.  Insulin-like growth factor 1 receptor stabilizes the ETV6-NTRK3 chimeric oncoprotein by blocking its KPC1/Rnf123-mediated proteasomal degradation.

Authors:  Cristina E Tognon; Bo Rafn; Naniye Malli Cetinbas; Takumi Kamura; Genny Trigo; Barak Rotblat; Fumihiko Okumura; Masaki Matsumoto; Christine Chow; Monika Davare; Michael Pollak; Thibault Mayor; Poul H Sorensen
Journal:  J Biol Chem       Date:  2018-06-14       Impact factor: 5.157

8.  SAM domain-dependent activity of PfTKL3, an essential tyrosine kinase-like kinase of the human malaria parasite Plasmodium falciparum.

Authors:  Abdirahman Abdi; Sylvain Eschenlauer; Luc Reininger; Christian Doerig
Journal:  Cell Mol Life Sci       Date:  2010-06-27       Impact factor: 9.261

9.  ALK Fusion Partners Impact Response to ALK Inhibition: Differential Effects on Sensitivity, Cellular Phenotypes, and Biochemical Properties.

Authors:  Merrida A Childress; Stephen M Himmelberg; Huiqin Chen; Wanleng Deng; Michael A Davies; Christine M Lovly
Journal:  Mol Cancer Res       Date:  2018-07-12       Impact factor: 5.852

10.  Sterile alpha motif domain-mediated self-association plays an essential role in modulating the activity of the Drosophila ETS family transcriptional repressor Yan.

Authors:  Jie Zhang; Thomas G W Graham; Pavithra Vivekanand; Lauren Cote; Maureen Cetera; Ilaria Rebay
Journal:  Mol Cell Biol       Date:  2010-01-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.